Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thalidomide: current and potential clinical applications.

L Calabrese1, A B Fleischer

  • 1Department of Rheumatic and Immunologic Disease, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio, USA.

The American Journal of Medicine
|April 27, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beneficial effects of upadacitinib on a subgroup of patients with atopic dermatitis and hidradenitis suppurativa: a multicenter, real-world retrospective study.

Frontiers in immunology·2026
Same author

Evidence of Avian Predation on a Critically Endangered Elasmobranch, the Halavi Guitarfish (<i>Glaucostegus halavi</i>), in the Red Sea.

Ecology and evolution·2026
Same author

Baseline patient-reported outcomes from UNITE: an observational, international, multicentre registry to evaluate hidradenitis suppurativa in clinical practice.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same author

African statue with goiter.

Journal of endocrinological investigation·2019
Same author

Cytology and molecular mechanisms of drug-induced gingival hypertrophy: a rewiew.

ORAL & implantology·2017
Same author

(18)F-FDG PET/CT versus bone scintigraphy in the follow-up of gastric cancer.

Revista espanola de medicina nuclear e imagen molecular·2015
Same journal

GLP-1 Receptor Agonists and Age-related Macular Degeneration Risk in Diabetes or Non-diabetic Obesity: A Retrospective Cohort Study.

The American journal of medicine·2026
Same journal

Marijuana Use and Acute Myocardial Infarction: Mechanistic Insights, Clinical Implications, and Emerging Challenges.

The American journal of medicine·2026
Same journal

Risk Factors for 30-day Hospital Readmission After Hospital-at-Home Treatment of Acute Pyelonephritis.

The American journal of medicine·2026
Same journal

Practice Changing Updates in Perioperative Medicine Literature 2025. A Systematic Review.

The American journal of medicine·2026
Same journal

Risk of Infection-Related Hospitalization Is More Than Doubled in Cushing's Syndrome vs Matched Controls.

The American journal of medicine·2026
Same journal

Chronic Inflammatory Diseases and Survival among Patients with Pancreatic Cancer in the U.S. Military Health System.

The American journal of medicine·2026
See all related articles

Thalidomide, known for its immunomodulatory effects, shows promise in treating various inflammatory and immune-related disorders. Strict safety protocols are essential due to its teratogenic potential.

Area of Science:

  • Immunology
  • Pharmacology
  • Dermatology

Background:

  • Thalidomide, withdrawn decades ago, is regaining interest for its immunomodulatory and anti-inflammatory properties.
  • It reduces tumor necrosis factor-alpha (TNF-alpha) and inhibits angiogenesis.
  • Approved for erythema nodosum leprosum, it's used off-label for immune dysregulation disorders.

Purpose of the Study:

  • To review the current evidence on thalidomide's efficacy and safety.
  • To highlight its therapeutic potential in various dermatologic and HIV-related conditions.
  • To emphasize the importance of risk management programs.

Main Methods:

  • Literature review of studies on thalidomide's mechanism of action, clinical applications, and adverse effects.
  • Analysis of its use in erythema nodosum leprosum, aphthous stomatitis, Behçet's syndrome, lupus erythematosus, graft-versus-host disease, and HIV-related conditions.

Related Experiment Videos

  • Examination of safety protocols to mitigate teratogenicity.

    • Main Results:

    • Thalidomide demonstrates efficacy in treating oral aphthous ulcers, HIV-associated wasting, HIV-related diarrhea, and Kaposi's sarcoma.
    • It is effective for erythema nodosum leprosum and other immune-related dermatologic conditions.
    • Comprehensive risk management programs are crucial for safe use.

    Conclusions:

    • Thalidomide offers therapeutic benefits for a range of disorders with inadequate treatments.
    • Its use requires strict monitoring for adverse effects like peripheral neuropathy, sedation, and constipation.
    • Appropriate safeguards can enable the safe and effective use of thalidomide.